Pharmacological Intervention to Modulate HDL: What Do We Target?
The cholesterol concentrations of low-density lipoprotein (LDL) and high-density lipoprotein (HDL) have traditionally served as risk factors for cardiovascular disease. As such, novel therapeutic interventions aiming to raise HDL cholesterol have been tested in the clinical setting. However, most tr...
Saved in:
Main Authors: | Nicholas J. Woudberg (Author), Sarah Pedretti (Author), Sandrine Lecour (Author), Rainer Schulz (Author), Nicolas Vuilleumier (Author), Richard W. James (Author), Miguel A. Frias (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HDL Subclass Distribution Shifts with Increasing Central Adiposity
by: Nicholas J. Woudberg, et al.
Published: (2019) -
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
by: Veronika Vyletelová, et al.
Published: (2022) -
Chapter L'eredità di Bruno Trentin per la sinistra europea
by: Pedretti, Ivan
Published: (2023) -
Chapter L'eredità di Bruno Trentin per la sinistra europea
by: Pedretti, Ivan
Published: (2023) -
HDL and glucose metabolism: Current evidence and therapeutic potential
by: Andrew Lloyd Siebel, et al.
Published: (2015)